在先天性中央低通风综合征中转氨基酶的升高
Rachel Y Wang1, Victoria S Wang2, Thomas G Keens1,3
1Keck School of Medicine, Los Angeles, CA, USA.
ERJ open research
|February 20, 2024
概括
出生性中央低通风综合征 (CCHS) 患者具有特定的并发症,如赫斯普隆病或肺高血压可能会出现肝酶升高. 建议对这些人定期监测肝功能.
科学领域:
- 儿科肺病学 儿科肺病学
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 遗传学 是一个遗传学.
背景情况:
- 先天性中央低通风综合征 (CCHS) 是一种罕见的遗传疾病,影响自主神经系统功能.
- CCHS患者经常出现复杂的并发症,包括胃肠道和心血管问题.
- 过氨基酶的升高可以表明肝功能障碍,这是慢性病的潜在并发症.
研究的目的:
- 为了在先天性中央低通风综合征 (CCHS) 中确定特定的患者亚组,这些患者有较高的转氨基酶升高风险.
- 突出CCHS并发症与肝功能之间的潜在关联.
- 为了告知临床实践关于肝功能监测在高风险的CCHS患者的需要.
主要方法:
- 对被诊断患有先天性中央低通风综合征 (CCHS) 的患者的回顾性图表审查.
- 分析患者数据,包括身体质量指数 (BMI),赫施普隆病的存在和肺高血压.
- 这些临床因素与记录的转氨酶水平和肝功能测试的相关性.
主要成果:
- 患有CCHS且表现为希尔施普朗格病的患者表现出对转氨基酶水平升高的倾向.
- 发现CCHS患者的BMI高或低也会增加肝酶升高的风险.
- 在CCHS患者中,肺高血压与异常转胺酶水平的可能性更高有关.
结论:
- 在先天性中央低通风综合征 (CCHS) 患者中,特定的并发症,包括赫什斯普隆病,BMI变异和肺高血压,与升高的转氨酶的风险增加有关.
- 定期监测肝功能对于这些相关疾病的CCHS患者至关重要.
- 早期识别和管理潜在的肝功能障碍可以改善CCHS患者的结果.
相关概念视频
01:30Acute Respiratory Failure-III
185
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
185
01:30Alterations in Respiration II
863
There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
863
01:21Acute Respiratory Failure-II
228
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
228
01:25Hyperpnea and Hyperventilation
1.1K
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
1.1K
01:21Acute Respiratory Failure-I
208
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
208
01:29Acute Respiratory Failure-V
139
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
139